{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-307795","form_type":"8-K","ticker":"ENGN","cik":"0001980845","company_name":"enGene Therapeutics Inc.","filed_at":"2026-07-17T20:05:21+00:00","discovered_at":"2026-07-17T20:07:00.757135+00:00","generated_at":"2026-07-17T20:07:10.512882+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"enGene updates corporate presentation; no specific financial or clinical details disclosed","bullets":["Filed under Item 7.01; presentation furnished as Exhibit 99.1, not deemed filed.","Presentation dated July 2026; content not provided in filing excerpt.","No new material financial, clinical, or operational data available from this filing.","Tickers: ENGN (common) and ENGNW (warrants) trade on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-307795","json":"https://secwatch.observer/filing/0001193125-26-307795.json","markdown":"https://secwatch.observer/filing/0001193125-26-307795.md","text":"https://secwatch.observer/filing/0001193125-26-307795.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1980845/000119312526307795/0001193125-26-307795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1980845/000119312526307795/engn-20260717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:07:10.512882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}